Analgesics and the kidney: a community-based study.
The adult population of a small Victorian town was interviewed for current analgesic consumption and the replies were validated by urine testing. One thousand four hundred and fifty-six subjects were ranked by stated analgesic consumption, and the 50 highest consumers matched for age and sex with non-consumers. Early morning urine specimens were collected and no significant difference in osmolality or white cell excretion rates was found between the two groups. It was concluded that the absolute risk of renal impairment on chronic analgesic consumers is low, and that patients on therapeutic regimens, including analgesics, may be reassured that any risk is minimal.
D000328:Adult; D000700:Analgesics; D001241:Aspirin; D001315:Australia; D005260:Female; D006801:Humans; D007674:Kidney Diseases / Q000453:epidemiology*; D007962:Leukocytes; D008297:Male; D008875:Middle Aged; D009994:Osmolar Concentration; D012459:Salicylates / Q000652:urine; D019966:Substance-Related Disorders / Q000453:epidemiology* / Q000652:urine; D014556:Urine / Q000166:cytology
D000700:Analgesics; D012459:Salicylates; D001241:Aspirin